Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphodiesterases with HD-GYP domains are bacterial enzymes belonging to the HD domain superfamily, uniquely equipped to hydrolyze cyclic di-GMP (bis-(3',5')-cyclic dimeric guanosine monophosphate)—a key bacterial second messenger controlling cellular processes such as biofilm formation, motility, and virulence[1][3][4]. HD-GYP phosphodiesterases contain conserved motifs (HD and GYP) that coordinate transition metal ions (commonly Fe) in their active site, essential for catalysis[4][6]. They frequently act in opposition to diguanylate cyclases (GGDEF domain proteins) to fine-tune cyclic dinucleotide levels[1]. By modulating signal transduction pathways, these enzymes critically affect bacterial adaptation and pathogenicity, making them candidate targets for anti-biofilm and antimicrobial drug design[2]. No clinically approved drugs yet target these enzymes, but mechanistic knowledge underpins current efforts in therapeutic inhibitor development[2].
Hydrolysis of cyclic di-GMP or related cyclic dinucleotides, converting them into linear di-nucleotides or mononucleotides Modulation of bacterial secondary messenger levels, thereby altering bacterial physiology and pathogenicity[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphodiesterase with HD-GYP domain (HD-GYP phosphodiesterase).